SpeechPathology.com Phone: 800-242-5183


EDU Healthcare Opportunities

Utilizing ABA in Dementia Management, Part 1: Dementia Types and Evidence-Based Practices

Utilizing ABA in Dementia Management, Part 1: Dementia Types and Evidence-Based Practices
Mary Beth Mason-Baughman, PhD, CCC-SLP
December 29, 2015
Share:

Today we are going to talk about Applied Behavior Analysis (ABA) in Dementia Management.  This is part 1 of a two-part series.  Part Two is later in September.  Today, we are going to do an overview of dementia types and current evidence-based practices, some of which utilize behavior management.  I have no financial or nonfinancial relationships relevant to the content of this course.  That means if I tell you about a treatment technique, test, or product, it is because I like it and I support it, not because I am going to make any money from it. 

I dedicate this presentation and every presentation I do that has anything to do with dementia to my dad.  He passed away on my birthday in February of 2011.  He had frontotemporal degeneration.  I like people to know that I have experience working with people with dementia from the professional side as a speech-language pathologist, but also from a personal perspective with my dad, with frontotemporal degeneration; and also my grandmother, who is still living and has Alzheimer’s. 

Learning Outcomes

Our learning outcomes, as a result of this continuing education activity, are that participants will be able to explain differences in clinical manifestations of Alzheimer’s disease versus vascular dementia versus frontotemporal degeneration; identify at least three treatment methods that have been proven effective for adults with dementia in recent research studies; and describe the rationale for using various evidence-based treatment approaches for different dementia types.

We are going to discuss the dementia types and then address the evidence-based practices (EBP) focusing on direct treatments and indirect treatments.  This information comes from the ASHA Compendiums.  I will give an introduction to applied behavior analysis and how we can apply that to working with patients with dementia.  Then I will do more of that in the second part of this presentation at a later date. 

Dementia Types

Let’s start with an overview of the dementia types.  Alzheimer’s is the most prevalent form of dementia.  Vascular dementia is typically always listed in the top three. 

I included frontotemporal degeneration because I have the personal connection to that.  I also think that many of us are seeing this type more and more.  We have younger patients that have a dementia diagnosis; sometimes it is not specifically frontotemporal degeneration, but there are patients with a more general dementia, with behavioral disturbances.  They are not the typical long-term care dementia patients that we are used to, where the disease takes the course of Alzheimer’s disease.  These are people who have issues that are really behavioral in nature, and I thought that it was an important dementia to touch upon in this discussion. 


mary beth mason baughman

Mary Beth Mason-Baughman, PhD, CCC-SLP

Mary Beth is an Associate Professor at Edinboro University.  Her teaching and research interests include adult neurogenic communication disorders, semantic feature knowledge in adults, gerontology, and professional issues.  She serves as Associate Coordinator for ASHA SIG 15 Gerontology and PSHA Vice President for Convention Planning and Program.



Related Courses

Treatment Approach Considerations for School-Aged Children with Speech Sound Disorders
Presented by Kathryn Cabbage, PhD, CCC-SLP
Video
Course: #9472Level: Intermediate1 Hour
This course will address the theoretical underpinnings and research base related to differential diagnosis and treatment of articulation and phonological deficits in children with speech sound disorders. Special considerations for how to tailor evaluation and intervention to meet the needs of school-age children will be discussed.

The Ripple Effect of Stuttering: A Community-Based Approach
Presented by Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow, Mary Weidner, PhD, CCC-SLP
Video
Course: #9217Level: Intermediate2 Hours
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video
Course: #9473Level: Intermediate1 Hour
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

20Q: Infection Control Strategies for SLPs
Presented by A.U. Bankaitis Smith, PhD
Text
Course: #9729Level: Intermediate1 Hour
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.

Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video
Course: #10497Level: Intermediate1 Hour
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.